|
|
|
Article Cited by others SYMPOSIUM FOR METRONOMICS AND ECONOMICS- REVIEW ARTICLE
Metronomic therapy: Chemotherapy revisited
Noronha V, Krishna M V, Patil V, Joshi A, Banavali S D, Prabhash K
Year : 2013| Volume: 50| Issue : 2 | Page no: 142-148 | This article has been cited by | | 1 |
Oral metronomic chemotherapy after definitive chemoradiation in esophageal squamous cell carcinoma: a randomized clinical trial |
|
| | V. Noronha, V. M. Patil, N. S. Menon, A. Joshi, S. Goud, S. More, S. Kannan, A. Pawar, D. Nakti, A. Yadav, S. Shah, A. Mahajan, A. Janu, R. Kumar, A. Tibdewal, N. Mummudi, J. P. Agarwal, S. D. Banavali, K. Prabhash | | | Esophagus. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Achievements and challenges in the use of metronomics for the treatment of breast cancer |
|
| | O. Graciela Scharovsky, María José Rico, Leandro E. Mainetti, Herman A. Perroud, Viviana R. Rozados | | | Biochemical Pharmacology. 2020; 175: 113909 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer |
|
| | Vijay M. Patil, Vanita Noronha, Amit Joshi, Sachin Dhumal, Manoj Mahimkar, Atanu Bhattacharjee, Vikram Gota, Manish Pandey, Nandini Menon, Abhishek Mahajan, Nilesh Sable, Suman Kumar, Kavita Nawale, Sadaf Mukadam, Bhavin Solanki, Sudeep Das, Vijai Simha, George Abraham, Arun Chandrasekharan, Vikas Talreja, Hollis DSouza, Sujay Srinivas, Lakhan Kashyap, Shripad Banavali, Kumar Prabhash | | | Journal of Clinical Oncology. 2019; 37(32): 3032 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
A Commentary: Herbal Medicine Offers Great Potential in Support of Metronomic Cancer Therapy |
|
| | Clara Bik-San Lau,Chun-Kwok Wong,Ping-Chung Leung | | | Journal of Cancer Therapy. 2017; 08(02): 86 | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Potential role of metronomic chemotherapy in the treatment of esophageal and gastroesophageal cancer |
|
| | Vanita Noronha,Vijay M. Patil,Amit Joshi,Anuradha Chougule,Shripad Banavali,Kumar Prabhash | | | Cancer Letters. 2017; 400: 267 | | | [Pubmed] [Google Scholar] [DOI] | | | 6 |
Cyclophosphamide and Bortezomib With Prednisone or Dexamethasone for the Treatment of Relapsed and Refractory Multiple Myeloma |
|
| | Donna E. Reece,Young Trieu,Esther Masih-Khan,Eshetu G. Atenafu,Christine Chen,Anca Prica,Rodger Tiedemann,Suzanne Trudel,Vishal Kukreti | | | Clinical Lymphoma Myeloma and Leukemia. 2016; 16(7): 387 | | | [Pubmed] [Google Scholar] [DOI] | | | 7 |
Metronomic cyclophosphamide eradicates large implanted GL261 gliomas by activating antitumor Cd8+T-cell responses and immune memory |
|
| | Junjie Wu,David J Waxman | | | OncoImmunology. 2015; 4(4): e1005521 | | | [Pubmed] [Google Scholar] [DOI] | | | 8 |
Phase I-II trial of oral cyclophosphamide, prednisone and lenalidomide for the treatment of patients with relapsed and refractory multiple myeloma |
|
| | Donna E. Reece,Esther Masih-Khan,Eshetu G. Atenafu,Victor H. Jimenez-Zepeda,Peter Anglin,Christine Chen,Vishal Kukreti,Joseph R. Mikhael,Suzanne Trudel | | | British Journal of Haematology. 2014; : n/a | | | [Pubmed] [Google Scholar] [DOI] | | | 9 |
Metronomic cyclophosphamide schedule-dependence of innate immune cell recruitment and tumor regression in an implanted glioma model |
|
| | Junjie Wu,David J. Waxman | | | Cancer Letters. 2014; 353(2): 272 | | | [Pubmed] [Google Scholar] [DOI] | | | 10 |
New insights into metronomic chemotherapy-induced immunoregulation |
|
| | Yi-Bin Hao,Shan-Yong Yi,Jing Ruan,Ling Zhao,Ke-Jun Nan | | | Cancer Letters. 2014; 354(2): 220 | | | [Pubmed] [Google Scholar] [DOI] | |
|
|
